Cargando…

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study

BACKGROUND: East Africa, where Leishmania donovani is prevalent, faces the highest burden world-wide of visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) coinfection. However, data on the risk and predictors of VL relapse are scarce. Such information is vital to target medical follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abongomera, Charles, Diro, Ermias, Vogt, Florian, Tsoumanis, Achilleas, Mekonnen, Zelalem, Admassu, Henok, Colebunders, Robert, Mohammed, Rezika, Ritmeijer, Koert, van Griensven, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848226/ https://www.ncbi.nlm.nih.gov/pubmed/29020196 http://dx.doi.org/10.1093/cid/cix607

Ejemplares similares

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
por: Abongomera, Charles, et al.
Publicado: (2017)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
por: van Griensven, Johan, et al.
Publicado: (2018)

Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia
por: Vogt, Florian, et al.
Publicado: (2018)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
por: Diro, Ermias, et al.
Publicado: (2015)

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
por: van Griensven, Johan, et al.
Publicado: (2014)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2020)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study
por: Abongomera, Charles, et al.
Publicado: (2018)

Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
por: Aderie, Endashaw M., et al.
Publicado: (2017)

Case Report: Atypical Presentation of Visceral Leishmaniasis: Two Cases from Northwest Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2021)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration
por: Mohammed, Rezika, et al.
Publicado: (2021)

A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?
por: van Griensven, Johan, et al.
Publicado: (2014)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Endris, Mengistu, et al.
Publicado: (2014)

Shigella Bacteremia in a Patient with Visceral Leishmaniasis
por: Endris, Mengistu, et al.
Publicado: (2013)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Hailu, Workagegnehu, et al.
Publicado: (2021)

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2019)

Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study
por: Diro, Ermias, et al.
Publicado: (2015)

Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
por: van Griensven, Johan, et al.
Publicado: (2014)

Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in Ethiopia
por: Kassa, Mekibib, et al.
Publicado: (2020)

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2019)

Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends
por: Gorski, Stanislaw, et al.
Publicado: (2010)

Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management
por: Ferede, Getachew, et al.
Publicado: (2017)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2016)

Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: Systematic review and meta-analysis
por: Abongomera, Charles, et al.
Publicado: (2020)

Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area
por: Guedes, Diego Lins, et al.
Publicado: (2022)

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
por: Mahajan, Raman, et al.
Publicado: (2015)

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
por: Naylor-Leyland, Gabriel, et al.
Publicado: (2022)

Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
por: van Henten, Saskia, et al.
Publicado: (2021)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV
por: Adriaensen, Wim, et al.
Publicado: (2020)

Prevalence of malnutrition and associated risk factors among adult visceral leishmaniasis patients in Northwest Ethiopia: a cross sectional study
por: Mengesha, Bewketu, et al.
Publicado: (2014)

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hrhp4g2s151n214vkb5vbirlmd